scholarly journals Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e54078 ◽  
Author(s):  
Maria B. Lyng ◽  
Anne-Vibeke Lænkholm ◽  
Qihua Tan ◽  
Werner Vach ◽  
Karina H. Gravgaard ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Estrogen Receptor ◽  
High Risk ◽  
Cancer Patients ◽  
Primary Breast Cancer ◽  
Breast Cancer Patients ◽  
Gene Expression Signatures ◽  
Estrogen Receptor Positive

scholarly journals Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG)

2017 ◽  
Vol 57 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Signe Korsgaard Skriver ◽  
Anne-Vibeke Laenkholm ◽  
Birgitte Bruun Rasmussen ◽  
Jürgen Handler ◽  
Bo Grundtmann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Patients ◽  
Cooperative Group ◽  
Breast Cancer Patients ◽  
Estrogen Receptor Positive ◽  
Postmenopausal Estrogen
Sign in / Sign up

Export Citation Format

Share Document